Active, not recruitingPHASE1, PHASE2NCT04145349
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
Studying Desmoplastic small round cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Eli Lilly and Company
- Principal Investigator
- Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company
- Intervention
- Ramucirumab(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 29 years · All sexes
- Timeline
- 2020 – 2026
Study locations (22)
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Washington University, St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
- Royal Children's Hospital, Parkville, Victoria, Australia
- Universitaetsklinikum Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, Germany
- Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardy, Italy
- Humanitas, Rozzano, Milano, Italy
- Ospedale Pediatrico Bambino Gesù, Rome, Roma, Italy
- Azienda Ospedaliera di Padova, Padua, Veneto, Italy
- National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04145349 on ClinicalTrials.govOther trials for Desmoplastic small round cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07328425Clinical Study in Patients With DSRCTItalian Sarcoma Group
- RECRUITINGPHASE2NCT06456359Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell TumorUniversity Hospital Heidelberg
- RECRUITINGPHASE1, PHASE2NCT05918640Lurbinectedin in FET-Fused TumorsChildren's Hospital of Philadelphia
- RECRUITINGNCT04690374Registry to Collect Health Information About Desmoplastic Small Round Cell TumorMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT04022213A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the PeritoneumMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT01946529Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsSt. Jude Children's Research Hospital
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT01189643Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorMemorial Sloan Kettering Cancer Center